Physician profile
David L Chen
NPI 1922364611
$853.17
in general payments reported to CMS, 2019-2025
11 companies · $42.09 in 2025
The $42.09 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $525 · 2023: $34.97 · 2025: $42.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $234.54 | 2021-2025 | Rinvoq |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $150.77 | 2021-2022 | |
| Genzyme Corporation | $102.40 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $90.76 | 2022 | |
| Amgen INC. | $83.88 | 2021-2022 | |
| Leo Pharma INC. | $62.56 | 2022 | |
| Janssen Biotech, INC. | $45.19 | 2021-2022 | |
| Lilly USA, LLC | $37.12 | 2021-2022 | |
| Incyte Corporation | $22.01 | 2022 | |
| Mayne Pharma Commercial LLC | $15.18 | 2021 | |
| Biofrontera INC. | $8.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.